← All companies
Intellia Therapeutics, Inc.
NTLA - Company ID 0001652130
Market cap$2.16 B
Rank#2076
Filings679
The table below shows Intellia Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $134.70M | $193.39M | $156.17M | $126.88M | $120.50M | $130.85M |
| Short-term investments | $241.29M | $317.65M | $303.48M | $376.87M | $537.62M | $560.22M |
| Receivables | $9.13M | $11.05M | $11.35M | $10.50M | $8.85M | $12.33M |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.